Ipsos Partners with Veterans Affairs in Fight Against COVID-19
Washington, DC, May 29, 2020 – Today, Ipsos, the global research firm,announced the launch of the Biosurveillance Atlas Initiative, an important collaboration with Department of Veterans Affairs (VA) and human mobility data provider Safegraph. The initiative will accelerate the development of an omni-channel data platform to arm VA decision-makers with actionable insights about the COVID19 pandemic.
The Biosurveillance Atlas will provide VA with real-time intelligence from over 50 structured and unstructured data streams, including disease progression trends, human mobility and social media analytics. This initiative will harness data in critical demand to unearth reliable and actionable insights for safely reopening VA infrastructure and will provide early warning signs for potential future waves of COVID-19. This pandemic’s effect on health systems, economies, and livelihoods is profound and long-term, and effective response requires an unprecedented collaboration across government, and private sector partners.
Dr. Clifford Young, President, Public Affairs at Ipsos stated, “We feel a shared responsibility to see if there are specific areas where a new collaborative partnership across multiple sectors, including the social research and the data sciences industries, with key public partners, such as the Department of Veterans Affairs, can accelerate solutions to this pandemic. This cooperative agreement will be a critical step in ensuring that accurate, triangulated and timely data is easily accessible to our nation’s leaders. It will ensure that decision-makers are making the most informed decisions possible at a moment’s notice, as this pandemic demands. I say unequivocally that such projects are why I, and others at Ipsos, get out of bed everyday—to serve the greater good.”
Ipsos’ partner on this initiative, SafeGraph, is lending its expansive point-of-interest (POI) and social distancing datasets to the digital architecture of the Atlas. SafeGraph Chief of Staff Ross Epstein said, “We are very excited to equip VA and Ipsos with accurate point-of-interest and foot traffic data directly within the Atlas product. Enabling VA to make decisions and save lives is all that matters in times like this.”
“We are encouraged by the enthusiasm of our partners to enhance the Biosurveillance Atlas for use by VA leadership during this unprecedent crisis and to ensure its applicability long after the pandemic has been regulated to our memories,” said Dr. Young. “This collaboration will provide VA with necessary tools for safer reopening of VA facilities for out-patient procedures as well as early warning system to detect potential future COVID-19 outbreaks next winter.”
The names of actual companies and products mentioned herein may be the trademarks of their respective owners.
For more information on this news release, please contact:
Sarah Saxton
Senior Vice President, US
Public Affairs
Ipsos
+1 908 399 3430
[email protected]
For more information on the Biosurveillance Atlas Initiative:
About Ipsos
Ipsos is the world’s third largest market research company, present in 90 markets and employing more than 18,000 people.
Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. We serve more than 5000 clients across the world with 75 business solutions.
Founded in France in 1975, Ipsos is listed on the Euronext Paris since July 1st, 1999. The company is part of the SBF 120 and the Mid-60 index and is eligible for the Deferred Settlement Service (SRD).
ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP www.ipsos.com
The publication of these findings abides by local rules and regulations.
